XML 28 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Revenues:      
Total revenues $ 50,335,167 $ 40,394,177 $ 47,401,190
Expenses:      
Cost of product revenues 36,164,120 24,952,431 32,558,748
Research and development-funded programs 3,802,372 7,177,027 10,279,660
Research and development-internal 5,832,782 3,600,066 8,387,898
Selling, general and administrative 22,844,719 21,842,157 17,965,097
Litigation damages 24,800,000
Total operating expenses 93,443,993 57,571,681 69,191,403
Loss from operations (43,108,826) (17,177,504) (21,790,213)
Non-operating (expense) income, net:      
Interest income 817,180 829,602 76,877
Other income, net 19,989 245,234 154,357
Foreign currency transaction gains (losses) 175,909 (162,204) (323,286)
(Loss) gain on remeasurement of investments (1,612,148) (3,327,347) 2,700,000
Total non-operating (expense) income (599,070) (2,414,715) 2,607,948
Loss before provision for income taxes and net loss of noncontrolling interest (43,707,896) (19,592,219) (19,182,265)
Tax provision (170,000) (156,000) (144,000)
Net loss (43,877,896) (19,748,219) (19,326,265)
Net loss attributable to the noncontrolling interest 348
Net loss attributable to Kopin Corporation $ (43,877,896) $ (19,748,219) $ (19,325,917)
Net loss per share:      
Basic $ (0.33) $ (0.18) $ (0.21)
Diluted $ (0.33) $ (0.18) $ (0.21)
Weighted average number of common shares outstanding:      
Basic 132,875,913 108,976,245 91,429,106
Diluted 132,875,913 108,976,245 91,429,106
Net Product Revenues [Member]      
Revenues:      
Total revenues $ 43,576,723 $ 25,937,170 $ 32,420,397
Research and Development Revenues [Member]      
Revenues:      
Total revenues 5,996,362 13,454,866 14,357,222
License and Other Revenues [Member]      
Revenues:      
Total revenues $ 762,082 $ 1,002,141 $ 623,571